{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:32:04Z","timestamp":1785789124006,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:00:00Z","timestamp":1570838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:00:00Z","timestamp":1570838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["2018kj05"],"award-info":[{"award-number":["2018kj05"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11064-019-02891-5","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T16:46:19Z","timestamp":1572453979000},"page":"2723-2732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Exerts Antidepressant-Like Effect in Mice"],"prefix":"10.1007","volume":"44","author":[{"given":"Xiaojing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,12]]},"reference":[{"key":"2891_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","volume":"176","author":"JL Phillips","year":"2019","unstructured":"Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, Owoeye O, Batten LA, Blier P (2019) Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry 176:401\u2013409. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2018.18070834","journal-title":"Am J Psychiatry"},{"key":"2891_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2018.05.001","volume":"170","author":"Y Wang","year":"2018","unstructured":"Wang Y, Xie L, Gao C, Zhai L, Zhang N, Guo L (2018) Astrocytes activation contributes to the antidepressant-like effect of ketamine but not scopolamine. Pharmacol Biochem Behav 170:1\u20138. \nhttps:\/\/doi.org\/10.1016\/j.pbb.2018.05.001","journal-title":"Pharmacol Biochem Behav"},{"key":"2891_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/1570159X15666170221101054","volume":"15","author":"S Chaki","year":"2017","unstructured":"Chaki S (2017) Beyond ketamine: new approaches to the development of safer antidepressants. Curr Neuropharmacol 15:963\u2013976. \nhttps:\/\/doi.org\/10.2174\/1570159X15666170221101054","journal-title":"Curr Neuropharmacol"},{"key":"2891_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","volume":"83","author":"S Ghosal","year":"2018","unstructured":"Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, Duman RS (2018) Activity-dependent brain-derived neurotrophic factor release is required for the rapid antidepressant actions of scopolamine. Biol Psychiatry 83:29\u201337. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2017.06.017","journal-title":"Biol Psychiatry"},{"key":"2891_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/s0140-6736(72)93021-8","volume":"2","author":"DS Janowsky","year":"1972","unstructured":"Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic\u2013adrenergic hypothesis of mania and depression. Lancet 2:632\u2013635. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(72)93021-8","journal-title":"Lancet"},{"key":"2891_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","volume":"63","author":"ML Furey","year":"2006","unstructured":"Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121\u20131129. \nhttps:\/\/doi.org\/10.1001\/archpsyc.63.10.1121","journal-title":"Arch Gen Psychiatry"},{"key":"2891_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/01.ftd.0000168293.48226.57","volume":"27","author":"UD Renner","year":"2005","unstructured":"Renner UD, Oertel R, Kirch W (2005) Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 27:655\u2013665","journal-title":"Ther Drug Monit"},{"key":"2891_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","volume":"67","author":"WC Drevets","year":"2010","unstructured":"Drevets WC, Furey ML (2010) Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatry 67:432\u2013438. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2009.11.021","journal-title":"Biol Psychiatry"},{"key":"2891_CR9","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1172\/JCI85033","volume":"126","author":"ES Wohleb","year":"2016","unstructured":"Wohleb ES, Wu M, Gerhard DM, Taylor SR, Picciotto MR, Alreja M, Duman RS (2016) GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest 126:2482\u20132494. \nhttps:\/\/doi.org\/10.1172\/JCI85033","journal-title":"J Clin Invest"},{"key":"2891_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nbd.2015.06.012","volume":"82","author":"A Navarria","year":"2015","unstructured":"Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE, Dwyer JM, Fuchikami M, Becker A, Drago F, Duman RS (2015) Rapid antidepressant actions of scopolamine: role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiol Dis 82:254\u2013261. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2015.06.012","journal-title":"Neurobiol Dis"},{"key":"2891_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","volume":"74","author":"B Voleti","year":"2013","unstructured":"Voleti B, Navarria A, Liu RJ, Banasr M, Li N, Terwilliger R, Sanacora G, Eid T, Aghajanian G, Duman RS (2013) Scopolamine rapidly increases Mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 74:742\u2013749. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2013.04.025","journal-title":"Biol Psychiatry"},{"key":"2891_CR12","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1021\/acschemneuro.8b00615","volume":"10","author":"AM Lakstygal","year":"2019","unstructured":"Lakstygal AM, Kolesnikova TO, Khatsko SL, Zabegalov KN, Volgin AD, Demin KA, Shevyrin VA, Wappler-Guzzetta EA, Kalueff AV (2019) DARK classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens. ACS Chem Neurosci 10:2144\u20132159. \nhttps:\/\/doi.org\/10.1021\/acschemneuro.8b00615","journal-title":"ACS Chem Neurosci"},{"key":"2891_CR13","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.bmcl.2005.02.071","volume":"15","author":"XY Han","year":"2005","unstructured":"Han XY, Liu H, Liu CH, Wu B, Chen LF, Zhong BH, Liu KL (2005) Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). Bioorg Med Chem Lett 15:1979\u20131982. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2005.02.071","journal-title":"Bioorg Med Chem Lett"},{"key":"2891_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/syn.21693","volume":"67","author":"TF Ma","year":"2013","unstructured":"Ma TF, Zhou L, Wang Y, Qin SJ, Zhang Y, Hu B, Yan JZ, Ma X, Zhou CH, Gu SL (2013) A selective M1 and M3 receptor antagonist, penehyclidine hydrochloride, prevents postischemic LTP: involvement of NMDA receptors. Synapse 67:865\u2013874. \nhttps:\/\/doi.org\/10.1002\/syn.21693","journal-title":"Synapse"},{"key":"2891_CR15","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.2147\/DDDT.S177435","volume":"12","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gao Y, Ma J (2018) Pleiotropic effects and pharmacological properties of penehyclidine hydrochloride. Drug Des Devel Ther 12:3289\u20133299. \nhttps:\/\/doi.org\/10.2147\/DDDT.S177435","journal-title":"Drug Des Devel Ther"},{"key":"2891_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41419-017-0014-7","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Chen S, Ni J, Cheng J, Jia J, Zhen X (2018) miRNA-3473b contributes to neuroinflammation following cerebral ischemia. Cell Death Dis 9:11. \nhttps:\/\/doi.org\/10.1038\/s41419-017-0014-7","journal-title":"Cell Death Dis"},{"key":"2891_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"2891_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.pnpbp.2019.04.010","volume":"93","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ni J, Gao C, Xie L, Zhai L, Cui G, Yin X (2019) Mitochondrial transplantation attenuates lipopolysaccharide- induced depression-like behaviors. Prog Neuro-Psychopharmacol Biol Psychiatry 93:240\u2013249. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2019.04.010","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2891_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/bf00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370. \nhttps:\/\/doi.org\/10.1007\/bf00428203","journal-title":"Psychopharmacology"},{"key":"2891_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/cns.12502","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang Y, Guo L, Jiang HF, Zheng LT, Zhang A, Zhen XC (2016) Allosteric modulation of sigma-1 receptors elicits rapid antidepressant activity. CNS Neurosci Ther 22:368\u2013377. \nhttps:\/\/doi.org\/10.1111\/cns.12502","journal-title":"CNS Neurosci Ther"},{"key":"2891_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neubiorev.2018.12.002","volume":"99","author":"S Antoniuk","year":"2019","unstructured":"Antoniuk S, Bijata M, Ponimaskin E, Wlodarczyk J (2019) Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability. Neurosci Biobehav Rev 99:101\u2013116. \nhttps:\/\/doi.org\/10.1016\/j.neubiorev.2018.12.002","journal-title":"Neurosci Biobehav Rev"},{"key":"2891_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00210-019-01632-3","volume":"392","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jiang HF, Ni J, Guo L (2019) Pharmacological stimulation of sigma-1 receptor promotes activation of astrocyte via ERK1\/2 and GSK3beta signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 392:801\u2013812. \nhttps:\/\/doi.org\/10.1007\/s00210-019-01632-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2891_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejps.2018.05.023","volume":"121","author":"M Feng","year":"2018","unstructured":"Feng M, Wang L, Chang S, Yuan P (2018) Penehyclidine hydrochloride regulates mitochondrial dynamics and apoptosis through p38MAPK and JNK signal pathways and provides cardioprotection in rats with myocardial ischemia-reperfusion injury. Eur J Pharm Sci 121:243\u2013250. \nhttps:\/\/doi.org\/10.1016\/j.ejps.2018.05.023","journal-title":"Eur J Pharm Sci"},{"key":"2891_CR24","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1179\/1743132813Y.0000000247","volume":"35","author":"Y Wang","year":"2013","unstructured":"Wang Y, Ma T, Zhou L, Li M, Sun XJ, Wang YG, Gu S (2013) Penehyclidine hydrochloride protects against oxygen and glucose deprivation injury by modulating amino acid neurotransmitters release. Neurol Res 35:1022\u20131028. \nhttps:\/\/doi.org\/10.1179\/1743132813Y.0000000247","journal-title":"Neurol Res"},{"key":"2891_CR25","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3892\/ijmm.2019.4117","volume":"43","author":"X Wu","year":"2019","unstructured":"Wu X, Kong Q, Xia Z, Zhan L, Duan W, Song X (2019) Penehyclidine hydrochloride alleviates lipopolysaccharideinduced acute lung injury in rats: potential role of caveolin1 expression upregulation. Int J Mol Med 43:2064\u20132074. \nhttps:\/\/doi.org\/10.3892\/ijmm.2019.4117","journal-title":"Int J Mol Med"},{"key":"2891_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1176\/appi.ajp.2012.11101546","volume":"169","author":"A Saricicek","year":"2012","unstructured":"Saricicek A, Esterlis I, Maloney KH, Mineur YS, Ruf BM, Muralidharan A, Chen JI, Cosgrove KP, Kerestes R, Ghose S, Tamminga CA, Pittman B, Bois F, Tamagnan G, Seibyl J, Picciotto MR, Staley JK, Bhagwagar Z (2012) Persistent beta2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry 169:851\u2013859. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2012.11101546","journal-title":"Am J Psychiatry"},{"key":"2891_CR27","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1111\/bph.13769","volume":"175","author":"YS Mineur","year":"2018","unstructured":"Mineur YS, Mose TN, Blakeman S, Picciotto MR (2018) Hippocampal alpha7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL\/6J mice. Br J Pharmacol 175:1903\u20131914. \nhttps:\/\/doi.org\/10.1111\/bph.13769","journal-title":"Br J Pharmacol"},{"key":"2891_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.neuropharm.2017.11.018","volume":"136","author":"EP Lebois","year":"2018","unstructured":"Lebois EP, Thorn C, Edgerton JR, Popiolek M, Xi S (2018) Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease. Neuropharmacology 136:362\u2013373. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.018","journal-title":"Neuropharmacology"},{"key":"2891_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu033","author":"AE Lepack","year":"2014","unstructured":"Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS (2014) BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol. \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyu033","journal-title":"Int J Neuropsychopharmacol"},{"key":"2891_CR30","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","volume":"175","author":"NR Williams","year":"2018","unstructured":"Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF (2018) Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry 175:1205\u20131215. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2018.18020138","journal-title":"Am J Psychiatry"},{"key":"2891_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.euroneuro.2011.08.002","volume":"22","author":"MJ Robson","year":"2012","unstructured":"Robson MJ, Elliott M, Seminerio MJ, Matsumoto RR (2012) Evaluation of sigma (sigma) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. Eur Neuropsychopharmacol 22:308\u2013317. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2011.08.002","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02891-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T23:46:18Z","timestamp":1602373578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2891"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02891-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,12]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}